CSIR-NIO's Vizag Centre to play key role in offshore energy: MoS (See 'Corp Brief') International Olympic Academy Director impressed by India's vision for sports (See 'Corp Brief') Assam Petro-Chemicals signs MoU with DPA to set up 150 TPD e-Methanol Plant at Kandla Port (See 'Corp Brief') WB ranks India among top 5 in terms of private investment in infra (See 'Corp Brief') Survey: India should focus on application-based AI tools (See 'Corp Brief') FEMA - Statement recorded u/s 37 of FEMA did not amount to confession of criminal offence: HC (See 'Legal Desk') UNCTAD ranks India as leading economy in trade partner diversification (See 'Corp Brief') Manufacturing GVA grows by 7.72% in Q1 and 9.1% in Q2 (See 'Corp Brief') SEBI - In absence of explicit permission/exemption with respect to RFQ requirements, Noticee should have suspended its services if it was not feasible to engage large amounts of funds into working capital: SEBI (See 'Legal Desk') The Securities Markets Code, 2025: Strengthened Enforcement, Weakened Accountability? (See 'CORP EINSICHT') India far more urban in functional terms than official definitions: Survey (See 'Corp Brief') Economic Survey lays stress on swadeshi for strategic resilience (See 'Corp Brief') 5G services now available in over 99% districts (See 'Corp Brief') Survey asks States to focus on entrepreneurial policy making (See 'Corp Brief') Health insurance accounts for 41% of Gross Domestic Premium (See 'Corp Brief') IBC - NCLT can't decide title disputes over assets, including IPRs such as trademarks, unless they have direct & proximate nexus with insolvency resolution process: SC (See 'Legal Desk') 'Vande Mataram', 'Anand Math', 'Atulya Bharat' tunes to regale audience at Beating Retreat ceremony (See 'Corp Brief') Youth Lead Democracy: Model Youth Gram Sabha Awards Conferred in Delhi (See 'Corp Brief') Misc - Execution sale during pendency of insolvency proceedings held void; Official Receiver can seek annulment even without expressly invoking Section 56: HC (See 'Legal Desk') Union fisheries secretary engages shrimp farmers, boosts scientific innovation in aquaculture (See 'Corp Brief') Learjet 45 aircraft VT-SSK crash at Baramati Airport of M/s VSR Ventures PVT LTD (See 'Corp Brief') SAFEMA - contravention of Sections 3(d) and 7(1)(a)can be established based on documentary evidence & circumstantial corroboration applying the standard of preponderance of probabilities, even in absence of direct evidence of cash payment: SAFEMA (See 'Legal Desk') CCI nod to acquisition of certain shareholding of Toyota Industries Corp (See 'Corp Brief') IBC - Resolution Professionals under IBC are public servants under Prevention of Corruption Act: HC (See 'Legal Desk') Department of Posts signs Agreement with Stock Holding Services Limited for access to capital market services (See 'Corp Brief') SEBI - Failure to make timely disclosure of material developments relating to a proposed scheme of arrangement & delayed disclosure of outcome of board meeting constitutes violation of LODR Regulations: SEBI (See 'Legal Desk') MSME beneficiaries invited as special guests for R-Day celebrations (See 'Corp Brief') PMLA - Offence of money-laundering is independent offence regarding process or activity connected with proceeds of crime which had been derived or obtained as result of criminal activity relating to or in relation to scheduled offence: SAFEMA (See 'Legal Desk')

Print

MoS reaffirms India's commitment to global pharmaceutical standardization

Published: Feb 06, 2025

By TIOLCorplaws News Service

NEW DELHI, FEB 06, 2025: UNION Minister of State for Health and Family Welfare, Anupriya Patel delivered the keynote address at the 15th International Meeting of World Pharmacopoeias (IMWP), hosted by the Indian Pharmacopoeia Commission (IPC) under the aegis of the Ministry of Health and Family Welfare, Government of India, in collaboration with the World Health Organization (WHO), here today. The meeting brought together global pharmacopoeial leaders, regulatory authorities, and industry stakeholders to deliberate on key issues related to pharmaceutical standards and harmonization.

Addressing the gathering, Patel reaffirmed India's commitment to global pharmaceutical standardization and regulatory convergence. She highlighted India's role as the "Pharmacy of the World" and emphasized the importance of ensuring access to high-quality medicines globally. She stated that the IMWP serves as a vital platform to foster international collaboration in pharmacopoeial science and regulatory harmonization.

On this occasion, the Union Minister also released the IPC Newsletter 2024 and a special IPC video film, which showcase India's advancements in pharmacopoeial science and the Commission's efforts in ensuring high-quality pharmaceutical standards. The video film can be accessed at the following link: https://www.youtube.com/watch?v=MCdAZodvOSM .

Punya Salila Srivastava, Secretary, Ministry of Health and Family Welfare, underscored the significance of global partnerships in strengthening pharmaceutical quality standards. She reiterated India's efforts in aligning regulatory frameworks with international best practices and ensuring the availability of safe and effective medicines worldwide.

Dr. Rajeev Singh Raghuvanshi, Secretary-cum-Scientific Director, IPC, and Drugs Controller General (India), highlighted IPC's contributions in setting global benchmarks in pharmacopoeial science. He elaborated on IPC's initiatives, including the IP Online platform, which enhances accessibility and usability of Indian Pharmacopoeia standards. He emphasized the role of scientific advancements and regulatory cooperation in shaping global pharmaceutical standards.

Dr. Roderico H. Ofrin, WHO Representative to India, commended India's leadership in pharmacopoeial standard-setting and emphasized the importance of regulatory harmonization in ensuring patient safety and public health.

The 15th IMWP is set to facilitate discussions on key focus areas, including:

- Updates on recommendations from the 14th IMWP and review of progress on harmonization initiatives.

- Emerging issues in impurity assessment (Q3) and the implications of ICH Q6 guidelines on pharmacopoeial monograph specifications.

- Defining the IMWP Charter to establish a long-term governance structure for the forum.

- Enhancing collaboration among global pharmacopoeias and regulatory bodies, with updates from the Pharmacopoeial Discussion Group (PDG).

- Promotion of environmental sustainability in pharmacopoeial practices and pharmaceutical manufacturing standards.

- Finalization of reports for the 15th IMWP and preparatory discussions for the 16th IMWP.

The deliberations during the IMWP will reinforce the role of pharmacopoeias in ensuring the quality, safety, and efficacy of medicines. The outcomes of the meeting will guide future collaborations in standard-setting and regulatory harmonization.

The 15th IMWP, which commenced today, will conclude on 7th February 2025. The discussions held over these three days will set the stage for further strengthening global pharmacopoeial cooperation and enhancing pharmaceutical quality assurance.

TIOL CORP SEARCH

TIOL GROUP WEBSITES

taxindiaonline
taxindiainternational
tioltube
TKF
TIOLawards
A TIOL Website. Copyright © 2025 TIOLcorplaws.com All rights reserved.